Brachytherapy Lab.
Explore the source. Follow the applicator. Understand the geometry of dose.
One source. A changing clock.
Select a radionuclide and advance time to see its remaining activity.
Every half-life, radioactive activity falls to half its previous value. This curve represents physical decay, not patient absorbed dose.
Iridium-192
An encapsulated gamma-emitting source is guided through an applicator by a remote afterloader.
²²⁴Ra → ²²⁰Rn → ²¹⁶Po → ²¹²Pb → ²¹²Bi → ²⁰⁸Pb (with branches through ²¹²Po or ²⁰⁸Tl). Some radioactive daughter atoms escape from the implanted source and spread through tissue before decaying. Alpha particles themselves have very short ranges; daughter transport extends the region exposed to them.
The graph shows remaining parent activity, not alpha emission rate from the complete chain. Alpha-DaRT is an investigational modality. This lab does not compute diffusion, seed spacing or alpha dosimetry; the tandem/ring views are separate conventional HDR teaching examples.
Watch dose take shape.
Follow the HDR source, let each dwell build a translucent dose bead, and watch neighbouring deposits merge around a fictional target.
How to read this teaching model
100% is a fixed teaching reference. Every elapsed dwell contributes to one summed three-dimensional dose field. The surface grows because more locations reach the selected dose; it does not show photons travelling slowly.
The inverse-square point-source approximation uses arbitrary spatial units and excludes a small source core from sampled volume metrics. The target and organs are fictional. Red means above the selected teaching threshold, not a toxicity limit; high dose close to a brachytherapy source is expected. An overrun means longer than the programmed teaching dwell.
This view is independent of the isotope selector and the DICOM workbench. It does not calculate Gy, source-specific TG-43 dose, attenuation, applicator shielding, transit dose, or a patient treatment plan. AAPM/ESTRO source dosimetry reference ↗
Three planes. One implant.
Explore the relationships among the cervix, bladder, rectum, tandem and vaginal ring in three linked anatomical planes. Move the crosshairs to inspect the same position in every view.
Redistribute the dwell weights.
Change relative contributions of conventional HDR tandem and ring source positions. This is not an alpha-emitter or DaRT dose model.
Two channel groups
The sliders distribute arbitrary relative contributions. They do not set treatment dwell times or patient dose.
Idealized point sources with an inverse-square kernel and a visualization-only near-source cap. No TG-43 radial-dose or anisotropy functions, applicator attenuation, heterogeneity or source calibration. Not a patient dose distribution.
Inspect image geometry and reference channels.
Import a local, de-identified single-frame CT or MR DICOM series. Browse the acquisition plane and two orthogonal reconstructions; place reference landmarks without uploading the images.
Use CarcinoLogica Contouring
The existing Contouring plugin remains the only contour editor. Import its native ZIP backup or read its local autosave on the same site to inspect real voxel masks read-only. Teaching Bridge continues to carry case summaries. For imported DICOM studies, masks appear only after exact image-content identity, spatial geometry verification and explicit teaching-only confirmation.
Applicator library · v0.10
Three local pathways: HDR intracavitary 25/30/35 mm; PDR Geneva and Venezia with a selectable needle insertion depth up to 50 mm. These are nominal configurations, not a commissioned applicator model. Needle depth does not define any radioactive dwell position.
Geometry profile schema and scientific safeguards
Import a JSON profile with format: "CarcinoLogica-AppGeometry-v1", unit: "mm", matching applicator_family and size_mm, three applicator-frame landmarks named tandem-tip, ring-centre, needle-reference, and arrays of 3D point coordinates for each channel. Download fictional profile example (NOT manufacturer geometry). On the DICOM image, mark the same physical three landmarks to compute a rigid alignment. The overlay is dashed and uncommissioned; no source-centre offsets or dwell positions are inferred.
The manufacturer descriptions are from Elekta Geneva and Elekta Venezia. HDR nominal sizes and the 0–50 mm PDR needle parameter are user-reported local configurations. PDR system compatibility is not independently verified. AAPM MPPG 13.a applies to Ir-192 HDR commissioning, not PDR.
Commissioning evidence · source-path QA
Record independently obtained measurements for the exact applicator and afterloader. This is a teaching evidence register, not a clinical commissioning certificate. Source offsets and dwell positions remain disabled.
Review manufacturer guidance and local physics procedures.
Read family-specific reference ↗ · AAPM MPPG 13.a (HDR scope) ↗
Device and source provenance (optional evidence fields)
All applicator paths uncommissioned.
No site-specific measurements recorded.
A recorded measurement or reviewer name does not establish a clinically validated source path. No tolerance is automatically assumed. Venezia curved-channel modelling, Geneva distal dwell checks, transfer tubes and PDR compatibility require separate site-specific physicist verification.
Know the model’s limits.
Primary sources, scope and what must be validated before adding quantitative planning.
IAEA Technical Reports Series No. 492
Dosimetry in Brachytherapy (2023), especially Section 3.4 and Table 3 (physical half-lives).
Open IAEA publication ↗AAPM TG-43U1 · Report 84
Source-specific brachytherapy dosimetry formalism. Source-specific TG-43 is not implemented; the 3D dose view uses an explicitly simplified teaching kernel.
Open AAPM report ↗AAPM / ESTRO Report 229
High-energy photon sources and consensus source-specific datasets, including Ir-192 and Co-60.
Open AAPM report ↗GEC-ESTRO Handbook · second edition
2025 gynaecological brachytherapy chapter. Requires MyESTRO login to read full content.
Open ESTRO library ↗US DOE / National Isotope Development Center
Radium-224: physical half-life 3.6319 days; first daughter 220Rn. Separate isotope-specific provenance from the conventional photon source list.
View NIDC reference ↗Alpha-DaRT dosimetry research
Dumančić et al., Medical Physics (2025), DOI 10.1002/mp.70052: measured progeny transport and diffusion/clearance across tumour models. Lielkajis et al., Medical Physics (2026), DOI 10.1002/mp.70494: Monte Carlo chain/diffusion dosimetry.
Read 2025 study ↗ · Read 2026 study ↗ESGO / ESTRO / ESP cervical cancer guidance (2023)
Image-guided adaptive brachytherapy, preferably using MRI with applicator in place; adapted targets and intracavitary ± interstitial approach according to anatomy and residual disease.
Read guideline ↗GYN GEC-ESTRO Working Group
Commissioning and applicator reconstruction in image-based cervical brachytherapy; image sequence selection, geometric uncertainty and pitfalls.
Read recommendations ↗DICOM PS3.3 · Image Plane Module
Authoritative mapping of pixel spacing, image orientation and image position into the patient LPS coordinate system.
View current standard ↗DICOM PS3.5 · Native encoding
Explicit VR Little Endian and Implicit VR Little Endian handling for uncompressed classic CT/MR. Compressed transfer syntaxes require decoders not included here.
View standard ↗What this release does—and does not—calculate
- Physical exponential radioactive decay (parent activity only for 224Ra).
- Rotatable 3D tandem-and-ring geometry, wireframe target and organs, and cumulative dose surfaces.
- Linked synthetic axial, sagittal and coronal reference diagrams with fictional target/OAR overlays.
- Local uncompressed single-frame CT/MR DICOM stack import, geometry-aware orthogonal views and manual anatomical landmarks (v0.3).
- Simulated dwell timing, automatic stepping, deliberate dwell holds and sampled volume coverage.
- Fixed-reference 3D inverse-square dose superposition and persistent hotspot regions. The separate 2D relative field remains locally normalized.
- TG-43 source-model datasets or Gy dosimetry.
- Clinical source dwell timing, calibrated transfer or machine QA.
- 224Ra decay-chain ingrowth, progeny diffusion, alpha transport or Alpha-DaRT treatment planning.
- Validated clinical contours, DVH or EQD2 (v0.7 can overlay read-only voxel masks from an existing Contouring backup on a confirmed matching image grid).
- DICOM-RT, dose prescriptions or patient planning; manually marked channel paths are not clinically reconstructed applicators.